Impact Factor
3.73
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.44
227 total citations
h5-index
23
h5 depth signal
Cited share
93.3%
42 of 45
Total citations
227
Citation footprint
Metric signal
5.29
External metric anchor
Self-citation
4.0%
9 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
83
China
62
India
31
United Kingdom
19
Canada
18
Citing Fields of Research
Pharmacology & Toxicology
153
Cancer Drugs
40
Molecular & Cellular Toxicology
36
Substance Abuse
24
Cellular Membrane Transporters & Receptors
18
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,749
Articles tracked across the journal lifetime
Indexed publication set
45
42 cited publications
Last 12 months
31
2.6 publications/month
Open access share
22.6%
7 OA publications in the last year
Leading citing country
United States
83 citing publications
Leading citing field
Pharmacology & Toxicology
153 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v2n1, 1973-
v2n1, 1973-
Active Coverage
Research Focus & Classification
Indexed Subjects
Pharmacology & Toxicology
Cancer Drugs
Inflammatory Bowel Diseases & Infections
Diabetes
Mass Spectrometry
Molecular & Cellular Toxicology
Broad Categories
Pharmacology
Pharmacology & Toxicology
Cancer Drugs
Substance Abuse
Molecular & Cellular Toxicology
Drug Delivery Systems
MeSH Descriptors
Pharmaceutical Preparations
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/03602532.2026.2743901
Open DOI
Rare Mendelian CYP disorders: from metabolic pathways to biomarker-guided diagnosis
Cytochrome P450 (CYP) enzymes are best known for xenobiotic metabolism, but many human CYPs also catalyze essential reactions in endogenous pathways governing steroidogenesis, bile acid and oxysterol turnover, vitamin D homeostasis, reti...
02
DOI 10.1080/03602532.2026.2745032
Open DOI
Physical Organic Chemistry in Biochemical Toxicology and the Career of Robert P. “Bob” Hanzlik
03
DOI 10.1080/03602532.2026.2730198
Open DOI
Reprogramming of hepatic drug metabolism following early-life xenobiotic exposure: insights from nuclear receptor pathways
04
DOI 10.1080/03602532.2026.2724981
Open DOI
Metabolic pharmacology of anthelmintic drugs targeting mitochondrial fumarate reductase in neurocysticercosis
1. Taenia solium is the causative agent of animal and human cysticercosis. When the larval oncospheres migrate and encyst within the central nervous system, they cause neurocysticercosis (NCC) the ...
05
DOI 10.1080/03602532.2026.2724971
Open DOI
Metabolism-driven hepatotoxicity of 5-fluorouracil: molecular mechanisms and future therapeutic directions
Drug-induced liver injury (DILI) is a significant and growing global health concern, encompassing hepatocellular damage caused by prescribed medications, over-the-counter drugs, herbal and dietary ...
06
DOI 10.1080/03602532.2026.2721999
Open DOI
SAR and mechanistic pathways of oxadiazole derivatives: targeting enzymes for antidiabetic therapy
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia resulting from impaired insulin secretion, insulin action, or both (Mehra 2024; Mehra et al. 2024). The g...
07
DOI 10.1080/03602532.2026.2697751
Open DOI
Humanized mouse models for drug metabolism and drug transport: a systematic review
Animal models are commonly used for prediction of human pharmacokinetics, however, due to species differences, there are often challenges in translation of the data to clinical outcomes. Humanized mice in the form of chimeric and transge...
08
DOI 10.1080/03602532.2026.2705851
Open DOI
Bioactivation and reactivity research advances – 2025 year in review
This 2025 review highlights significant findings and key advances in bioactivation and reactivity research that not only address fundamental mechanistic questions but also provide practical advance...
09
DOI 10.1080/03602532.2026.2688186
Open DOI
Herbal supplements and anti-tuberculosis therapy: unlocking hidden interactions for better multidrug-resistant tuberculosis management
Tuberculosis (TB), especially in its multidrug-resistant form (MDR-TB), remains a persistent threat to global health despite decades of medical advancements. Standard treatment regimens often involve complex drug combinations, which, whi...
10
DOI 10.1080/03602532.2026.2690529
Open DOI
Drug Transporters in Drug Disposition – Highlights from the Year 2025
On behalf of my co-authors I am pleased to present our sixth annual review highlighting articles that have been deemed as impactful in the field of drug transporter sciences. Drug transporters influence the absorption, distribution, and ...
Bibliographical & Catalog Notes
Imprint varies.
Print issues ceased with v. 45 (2013).
Supplements accompany some vols.
Also issued online.
Vol. 14, no. 5 (1985)19890915 Notice published Printed on acid-free paper